OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Tianyi Zhang, Yanxian Ren, Pengfei Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 92

Showing 26-50 of 92 citing articles:

KRT7 promotes pancreatic cancer metastasis by remodeling the extracellular matrix niche through FGF2-fibroblast crosstalk
Yuting Jiang, Cheng‐Yu Liao, Jianlin Lai, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Polysaccharides as therapeutic vehicles in pancreatic cancer
Seema Kumari, Sujatha Peela, Ganji Purnachandra Nagaraju, et al.
Drug Discovery Today (2025), pp. 104320-104320
Closed Access

Circulating tumour cells in gastrointestinal cancers: food for thought?
Simran Asawa, Manuel Nüesch, Ana Gvozdenovic, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 11, pp. 1981-1990
Open Access | Times Cited: 11

Co-expression patterns of cancer associated fibroblast markers reveal distinct subgroups related to patient survival in oropharyngeal squamous cell carcinoma
Su Ir Lyu, Jannik Johannsen, Adrian Georg Simon, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4

The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives
Fotini Poyia, Christiana M. Neophytou, Maria Christodoulou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9555-9555
Open Access | Times Cited: 4

Isorhamnetin exerts anti-proliferative effect on cancer-associated fibroblasts by inducing cell cycle arrest
Munkhzul Ganbold, Pakavarin Louphrasitthiphol, Takafumi Miyamoto, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117954-117954
Closed Access

Immune-Based Strategies for Pancreatic Cancer in the Adjuvant Setting
Kaili Liang, Nilofer S. Azad
Cancers (2025) Vol. 17, Iss. 7, pp. 1246-1246
Open Access

Cancer-Associated Fibroblasts in Gastrointestinal Cancers: Unveiling Their Dynamic Roles in the Tumor Microenvironment
Nour Al-Bzour, Ayah N. Al-Bzour, Obada Ababneh, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16505-16505
Open Access | Times Cited: 10

Novel selective inhibitors of macropinocytosis-dependent growth in pancreatic ductal carcinoma
Silvia Brambillasca, Maria Rosaria, Adrian Andronache, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116991-116991
Open Access | Times Cited: 3

Surface-Enhanced Raman Scattering Monitoring of Tryptophan Dynamics in 3D Pancreatic Tumor Models
Pablo S. Valera, Margarida Henriques-Pereira, Marita Wagner, et al.
ACS Sensors (2024) Vol. 9, Iss. 8, pp. 4236-4247
Open Access | Times Cited: 3

3D in vitro modeling of the exocrine pancreatic unit using tomographic volumetric bioprinting
Viola Sgarminato, Jorge Madrid‐Wolff, Antoine Boniface, et al.
Biofabrication (2024) Vol. 16, Iss. 4, pp. 045034-045034
Closed Access | Times Cited: 3

Spatial proteomic profiling elucidates immune determinants of neoadjuvant chemo-immunotherapy in esophageal squamous cell carcinoma
Chao Wu, Guoqing Zhang, Lin Wang, et al.
Oncogene (2024) Vol. 43, Iss. 37, pp. 2751-2767
Closed Access | Times Cited: 3

Development of Dual Diagnostic-Therapeutic Nanoformulation Effective Against Pancreatic Cancer in Animal Model
Yanan Huang, Yunfeng Wang, Tianyu Zheng, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 9121-9143
Open Access | Times Cited: 3

Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer
Raphaël Peiffer, Yasmine Boumahd, Charlotte Gullo, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 61-61
Open Access | Times Cited: 13

Isolation and characterization of cancer-associated fibroblasts in the tumor microenvironment of hepatocellular carcinoma
K S Mun, Ji Won Han, Pureun Roh, et al.
Journal of Liver Cancer (2023) Vol. 23, Iss. 2, pp. 341-349
Open Access | Times Cited: 7

Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer
Marco Erreni, Maria Rita Fumagalli, Damiano Zanini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1389-1389
Open Access | Times Cited: 2

ITGB6 promotes pancreatic fibrosis and aggravates the malignant process of pancreatic cancer via JAK2/STAT3 signaling pathway
Yanwen Zhang, Zhiyuan Chen, Shen Zhengchao, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 6093-6106
Closed Access | Times Cited: 2

Pancreatic cancer cell- and cancer-associated fibroblast-derived exosomes in disease progression, metastasis, and therapy
Yijun Chen, Jörg Kleeff, Yoshiaki Sunami
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2

EBF1-COX4I2 signaling axis promotes a myofibroblast-like phenotype in cancer-associated fibroblasts (CAFs) and is associated with an immunosuppressive microenvironment
Jie-pin Li, Yuan-jie Liu, Shuangshuang Wang, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112666-112666
Open Access | Times Cited: 2

Breaking Down Barriers in Drug Delivery by Stromal Remodeling Approaches in Pancreatic Cancer
Ying Zhou, Yunxiao Ma, Jingdan Sheng, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 2

Scroll to top